治疗决策和治疗经验在男性转移性割抵抗性前列腺癌的男性
Sandra Doveson1, Per Fransson2, Lena Axelsson3
1Department of Nursing Science, Sophiahemmet University, Stockholm, Sweden; Department of Health Care Science, Marie Cederschiöld University, Stocholm, Sweden. sandra.doveson@shh.se.
Acta oncologica (Stockholm, Sweden)
|March 24, 2025
概括
患有转移性割抵抗性前列腺癌 (mCRPC) 的男性报告说,他们对医疗保健沟通的满意度很高,但对治疗效果的讨论较少. 探索患者的偏好和促进共享决策对于改善护理至关重要.
科学领域:
- 在瘤学瘤学.
- 患者体验研究 研究研究
- 卫生沟通健康沟通
背景情况:
- 转移性割抵抗性前列腺癌 (mCRPC) 在延长寿命的治疗方面取得了进展.
- 了解患者对治疗决策 (TDM) 和经验的满意度至关重要,但研究不足.
研究的目的:
- 描述患者对TDM的满意度和生命延长mCRPC治疗的前12个月的治疗经验.
- 探索TDM满意度与随后的治疗经验和幸福感之间的关联.
主要方法:
- 对104名患有mCRPC的男性进行了前性研究,他们接受了为期12个月的终身治疗.
- 每四个月一次的问卷调查评估了TDM满意度,治疗经验和幸福感.
- 相关性分析检查了基线TDM满意度和结果之间的联系.
主要成果:
- 报告的医生/护士沟通和信任的高满意度 (>55%).
- 对讨论治疗副作用的满意度较低 (40%报告没有讨论).
- 治疗经验和幸福感保持稳定;基线TDM满意度与整体治疗评级和幸福感相关.
结论:
- 患有mCRPC的男性通常经历稳定的治疗结果和幸福感.
- 关于治疗对日常生活的影响存在沟通缺口.
- 促进共享决策和探索患者偏好对于优化mCRPC护理至关重要.
相关概念视频
Disorders of the Male Reproductive System
283
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
283
Cancer Survival Analysis
313
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
313
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


